Summary.-Animals treated with a sufficiently high dose of busulphan die about 14 days later from bone marrow failure. A single, appropriately timed injection of cyclophosphamide can save these mice. The nature of this protection is shown to be the cyclophosphamide induced elaboration of a humoral factor which stimulates haemopoietic recovery. THE USE of cytotoxic agents in cancer chemotherapy is often limited by the action of these agents on the normal, homoeostatic, proliferating cells of the body, particularly those of the bone marrow. Any substance which enhances haemopoietic recovery, particularly during bone marrow depression induced by cyto-toxic agents, is of importance. Cyclophosphamide, in addition t
The hemopoietic potentials of three immunomodulators, Bestatin, OK-432 and Ge-132, were compared in ...
BACKGROUND: Cyclophosphamide (CPA) is an anti- cancer drug, used in chemotherapy. This is a toxic dr...
Cyclophosphamide (CTX) increases the antitumor effectiveness of adoptive immunotherapy in mice, and ...
The synergic action of the cytostatic drug cyclophosphamide (CP) and fragmented exogenous DNA causes...
Fifty children were induced with busulphan and cyclophosphamide before bone marrow transplantation. ...
Low dose cyclophosphamide (CTX) is protective against a subsequent challenge with a lethal dose of t...
A number of different alkylating chemotherapeutic agents - busulphan, dimethylbusulphan (DMB), isopr...
A number of different alkylating chemotherapeutic agents - busulphan, dimethylbusulphan (DMB), isopr...
Cyclophosphamide is an alkylating agent developed in the 1960s for the use in treatment of cancerous...
Cyclophosphamide (Cytoxan; Cy) is an alkylating agent with immunosuppressive and cytotoxic action. T...
Summary.-BDF ' mice were inoculated with 106 leukaemic cells and, together with control mice, w...
Cyclophosphamide (CY), the agent with cytoreductive activity, is widely exploited in cancer chemothe...
Aplastic anaemia (AA) is a potentially fatal failure of haemopoiesis of unknown aetiology. In some c...
The authors used the competitive repopulation assay and simple statistical analyses to estimate conc...
Summary.-The effect of cyclophosphamide on MSV-H oncogenesis and the immune response of young mice h...
The hemopoietic potentials of three immunomodulators, Bestatin, OK-432 and Ge-132, were compared in ...
BACKGROUND: Cyclophosphamide (CPA) is an anti- cancer drug, used in chemotherapy. This is a toxic dr...
Cyclophosphamide (CTX) increases the antitumor effectiveness of adoptive immunotherapy in mice, and ...
The synergic action of the cytostatic drug cyclophosphamide (CP) and fragmented exogenous DNA causes...
Fifty children were induced with busulphan and cyclophosphamide before bone marrow transplantation. ...
Low dose cyclophosphamide (CTX) is protective against a subsequent challenge with a lethal dose of t...
A number of different alkylating chemotherapeutic agents - busulphan, dimethylbusulphan (DMB), isopr...
A number of different alkylating chemotherapeutic agents - busulphan, dimethylbusulphan (DMB), isopr...
Cyclophosphamide is an alkylating agent developed in the 1960s for the use in treatment of cancerous...
Cyclophosphamide (Cytoxan; Cy) is an alkylating agent with immunosuppressive and cytotoxic action. T...
Summary.-BDF ' mice were inoculated with 106 leukaemic cells and, together with control mice, w...
Cyclophosphamide (CY), the agent with cytoreductive activity, is widely exploited in cancer chemothe...
Aplastic anaemia (AA) is a potentially fatal failure of haemopoiesis of unknown aetiology. In some c...
The authors used the competitive repopulation assay and simple statistical analyses to estimate conc...
Summary.-The effect of cyclophosphamide on MSV-H oncogenesis and the immune response of young mice h...
The hemopoietic potentials of three immunomodulators, Bestatin, OK-432 and Ge-132, were compared in ...
BACKGROUND: Cyclophosphamide (CPA) is an anti- cancer drug, used in chemotherapy. This is a toxic dr...
Cyclophosphamide (CTX) increases the antitumor effectiveness of adoptive immunotherapy in mice, and ...